Views: 0 Author: Site Editor Publish Time: 2026-09-14 Origin: Site
Cyclopentanecarbaldehyde (CAS No. 872-53-7)—also frequently designated across global chemical registries as cyclopentanecarboxaldehyde, formylcyclopentane, or cyclopentanecarbonal—is a pivotal cycloaliphatic aldehyde intermediate represented by the molecular formula C6H10O (Molecular Weight: 98.14 g/mol). Structurally characterized by a highly reactive formyl group (-CHO) directly tethered to a saturated five-membered carbocyclic ring, this versatile compound serves as a foundational building block across advanced active pharmaceutical ingredient (API) synthesis, specialty crop protection formulations, and high-purity fine chemical manufacturing.
For corporate procurement directors, process development chemists, and strategic supply chain leads navigating multi-stage commercial campaigns, securing industrial-grade Cyclopentanecarbaldehyde requires an exhaustive evaluation of its synthetic reactivity patterns, critical physical release parameters, analytical control protocols, safe storage requirements, and primary manufacturing capabilities.
The sustained industrial demand for CAS No. 872-53-7 across human health pipelines and agrochemical development is driven by the unique geometric properties of the cyclopentyl moiety combined with the strong electrophilicity of the terminal carbonyl carbon.

In modern medicinal chemistry, replacing linear or overly flexible alkyl chains with saturated five-membered carbocyclic frameworks represents a key molecular design strategy. Incorporating the cyclopentyl ring delivers distinct therapeutic, structural, and metabolic advantages:
By locking flexible side chains into a semi-rigid 3D spatial orientation, the cyclopentyl core reduces entropic penalties upon binding to target receptor pockets. This structural constraint significantly enhances target binding affinity, potency, and subtype selectivity.
Substituting a cyclopentyl ring adjacent to pharmacophores protects the molecule against rapid oxidative clearance mediated by hepatic cytochrome P450 enzymes (particularly CYP3A4 and CYP2D6 isoforms). This spatial shielding extends systemic half-life and improves overall pharmacokinetic profiles.
The hydrophobic five-membered carbocyclic ring modulates the lipophilicity profile (octanol-water partition coefficient, log P), optimizing membrane permeability, passive cellular absorption, and blood-brain barrier passage for central nervous system (CNS) targets.
The formyl functional group of Cyclopentanecarbaldehyde acts as an exceptionally versatile chemical handle, enabling diverse, high-yielding synthetic pathways under scalable plant operating conditions:
Reacts readily with primary or secondary aliphatic and aromatic amines in the presence of hydride donors (such as sodium triacetoxyborohydride, sodium cyanoborohydride, or catalytic H2/Pd-C systems) to yield cyclopentylmethylamine derivatives. These structures serve as core pharmacophores in central nervous system agents, centrally acting analgesics, and cardiovascular therapeutics.
Undergoes smooth Wittig, Horner-Wadsworth-Emmons (HWE), and Peterson olefination reactions with diverse phosphonium Ylides or stabilized phosphonates. This path yields alpha,beta-unsaturated esters, vinylcyclopentanes, and extended conjugated intermediates essential for total synthesis campaigns.
Converts cleanly upon exposure to organometallic reagents (organolithium compounds, Grignard reagents, organozinc species) into secondary cyclopentyl carbinols without triggering competing sterically hindered side reactions or self-condensation.
Acts as a strong electrophilic acceptor in base- or acid-catalyzed aldol additions, tandem condensation cascades, and multi-component reactions (e.g., Ugi, Passerini, or Biginelli-type reactions) to assemble complex spirocyclic, lactone, and fused bicyclic scaffolds.
To ensure predictable, reproducible performance during large-scale commercial API production runs, industrial batches of Cyclopentanecarbaldehyde must strictly comply with comprehensive analytical quality control standards prior to plant reactor charging:
| Technical Parameter | Technical Grade Target | Pharma Grade Release Standard | Primary Analytical Method | Operational & Industrial Purpose |
|---|---|---|---|---|
| Appearance | Clear liquid | Clear, colorless liquid | Visual Inspection | Confirms absolute liquid clarity and freedom from suspended particulates, oxidative hazing, or polymer buildup. |
| Purity Assay (GC) | >= 98.0% | >= 99.0% | Gas Chromatography (GC-FID) | Prevents unreacted organic impurities from consuming expensive late-stage reagents or disrupting API crystallization. |
| Moisture Content | <= 0.50% (5000 ppm) | <= 0.10% (1000 ppm) | Karl Fischer Titration | Critical for protecting water-sensitive organometallic reagents, hydride reductions, or air-sensitive coupling catalysts. |
| Boiling Point | 140 °C to 142 °C | 140 °C to 142 °C | Standard Distillation | Validates physical identity and thermal fraction behavior during plant solvent recovery and distillation cycles. |
| Density (at 20 °C) | 0.915 to 0.925 g/cm³ | 0.918 to 0.922 g/cm³ | Digital Densitometry | Guarantees precise volumetric mass-balance calculations during automated industrial plant charging. |
| Refractive Index | 1.444 to 1.448 (nD20) | 1.445 to 1.447 (nD20) | Refractometry | Delivers fast, non-destructive secondary identity verification prior to warehouse release. |
| Acidity (as Acid) | <= 1.0% | <= 0.3% (Cyclopentanecarboxylic Acid) | Acid-Base Titration / GC | Limits trace carboxylic acid formed by ambient oxidation that could alter pH-sensitive reaction steps. |
| Stabilizer / Blanket | Trace BHT / N2 | Trace BHT (~0.1%) / N2 | GC / Quantitative Assay | Prevents radical-mediated autoxidation and self-condensation during extended storage and international transit. |
As an aliphatic aldehyde, Cyclopentanecarbaldehyde is inherently susceptible to radical-mediated autoxidation upon exposure to ambient air, forming cyclopentanecarboxylic acid. Maintaining product purity requires stringent storage precautions and industrial packaging standards:

Product is packaged in light-shielded, heavy-gauge steel drums, specialized high-density polyethylene (HDPE) lined containers, or stainless steel ISO tanks equipped with a continuous dry nitrogen headspace purge to displace atmospheric oxygen.
Stainless steel fittings paired with PTFE (Teflon) or Kalrez gaskets are mandatory to prevent seal degradation or trace leaching during extended transportation cycles.
Maintained in cool, dry, explosion-proof hazardous material storage zones below 25 °C (with dedicated cold-chain storage at 2 °C to 8 °C recommended for long-term inventory holdings). Drums must remain tightly sealed under nitrogen until immediate point-of-use.
Strictly isolated from strong oxidizing agents, mineral acids, strong bases, and active peroxides to prevent violent exothermic reactions or rapid polymerizations.
Fully categorized under international transport frameworks for hazardous materials (Flammable Liquid, UN 1989, Class 3, Packing Group II/III).
Every commercial shipment is accompanied by detailed Safety Data Sheets (SDS), REACH compliance filings where applicable, and lot-specific Certificates of Analysis (CoA) backed by primary analytical data.
Securing multi-kilogram allocations for clinical development or multi-ton continuous volume for commercial drug manufacturing requires direct collaboration with an established primary chemical manufacturer. EASTFINE provides global pharmaceutical developers and fine chemical buyers with supply resilience, regulatory backing, and technical alignment:
Single-site manufacturing dependencies introduce severe supply chain risks stemming from regional environmental audits, scheduled facility turnarounds, or unexpected localized logistics disruptions. EASTFINE operates two primary production facilities located in Dalian and Heze:
Guarantees continuous production capability with immediate secondary site fallback options to eliminate delivery bottlenecks and project delays.
Accommodates flexible demand shifts, transitioning seamlessly from multi-kilogram pilot batches for preliminary R&D up to multi-ton commercial production runs.
Supported by an internal chemical research team holding 19 invention patents and 8 utility model patents, EASTFINE focuses on process route optimization, high atom economy, and yield maximization. Purchasing directly from a primary producer eliminates intermediary trading markups while opening direct technical communication with process development engineers.
EASTFINE facilities operate in strict compliance with ISO 9001 (Quality Management), ISO 14001 (Environmental Management), and ISO 45001 (Occupational Health and Safety) frameworks. Every production batch undergoes full analytical testing (GC-MS, HPLC, Karl Fischer, and NMR spectroscopy). Complete lot traceability, archival sample retention, and full regulatory documentation support seamless customer facility audits and global regulatory filings.

Cyclopentanecarbaldehyde (CAS No. 872-53-7) remains a fundamental carbocyclic building block for advancing complex active pharmaceutical ingredients and high-performance agricultural chemistry. By pairing dual-site manufacturing redundancy with direct primary producer R&D expertise, EASTFINE serves as a dependable, long-term supply partner for the global life science and chemical industries.
Contact EASTFINE's commercial sales team to request evaluation samples, review technical dossiers, or reserve campaign volume allocations.
Commercial Sourcing & Market Analysis: Cyclobutanone (CAS No. 1191-95-3)
Agrochemical Market Analysis & Sourcing Strategy: N-Isopropylmethylamine (CAS No. 4747-21-1)
Commercial Sourcing & Market Analysis: N-Isopropylmethylamine (CAS No. 4747-21-1)
Global Agrochemical Supply Chain Analysis: N-Isopropylmethylamine (CAS No. 4747-21-1)